Chronic Apical PeriodontitisNCT07529964
MMP-2/3 and Periapical Healing Outcomes
An observational study of Chronic Apical Periodontitis and Periapical Healing, run by TC Erciyes University.
Trial summary
This prospective randomized clinical study will investigate the association between MMP-2 and MMP-3 gene polymorphisms and radiographic healing outcomes following nonsurgical root canal treatment in patients with chronic apical periodontitis. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Chronic Apical Periodontitis, Periapical Healing
- What is being tested?
- Nonsurgical Root Canal Treatment
- Type of treatment
- Surgery or procedure
- How many people
- 50 participants
- Where
- No sites listed yet
- Study dates
- 15 May 2026to 25 Jun 2027
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population will consist of adult patients aged 18-65 years diagnosed with chronic apical periodontitis in single-rooted teeth and requiring primary nonsurgical root canal treatment. All participants will be classified as ASA I or II and will be recruited from patients referred to the Department of Endodontics. Only individuals meeting the predefined inclusion and exclusion criteria will be enrolled. Participants will undergo standardized treatment and follow-up under controlled clinical conditions.
Who may be able to join
- Single-rooted teeth
- PAI score ≥ 3
- Fully developed root apices
- Periodontal probing depth less than 5 mm
- Indication for primary nonsurgical root canal treatment
Who cannot join
- Previous endodontic treatment in the selected tooth
- Diagnosis of symptomatic apical abscess
- Presence of root fracture or internal/external resorption
- Use of systemic antibiotics within the previous 4 weeks
- Analgesic intake within 48 hours before treatment
- Ongoing immunosuppressive therapy
- Pregnancy or breastfeeding
About this study
Official title: Association of MMP-2 and MMP-3 Polymorphisms With 12-Month Radiographic Healing After Nonsurgical Root Canal Treatment in Chronic Apical Periodontitis: A Prospective Clinical Study
This prospective randomized clinical study will investigate the association between MMP-2 and MMP-3 gene polymorphisms and radiographic healing outcomes following nonsurgical root canal treatment in patients with chronic apical periodontitis. A total of 50 patients will undergo standardized endodontic treatment and will be followed for 12 months. Genotyping will be performed using baseline DNA samples, and periapical healing will be assessed using the Periapical Index (PAI). The relationship between genetic variations and treatment outcomes will be analyzed to determine whether host-related genetic factors influence healing patterns after root canal therapy.
- Conditions
- Chronic Apical Periodontitis, Periapical Healing
- Being tested
- Nonsurgical Root Canal Treatment
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Nonsurgical Root Canal TreatmentProcedure or surgery
All participants will undergo standardized nonsurgical root canal treatment performed under a uniform clinical protocol. After local anesthesia and rubber dam isolation, working length will be determined electronically and radiographically. Root canal preparation will be completed with rotary instrumentation up to size 30/.06, accompanied by sodium hypochlorite irrigation, EDTA, and ultrasonic activation. Canals will then be obturated in the same visit using gutta-percha and epoxy resin-based sealer with the warm vertical condensation technique. Periapical healing outcomes at 12 months will be evaluated in relation to MMP-2 and MMP-3 genetic polymorphisms.
| Study group | Role | What they receive |
|---|---|---|
| Standardized Root Canal Treatment | Participants will undergo standardized nonsurgical root canal treatment using a uniform clinical protocol. Radiographic healing outcomes will be evaluated at 12 months, and results will be analyzed in relation to MMP-2 and MMP-3 gene polymorphisms. Receives: Procedure: Nonsurgical Root Canal Treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Radiographic Periapical Healing
The primary outcome will be radiographic healing assessed using the Periapical Index (PAI) scoring system on standardized periapical radiographs.
Measured: 12 months after treatment
Secondary outcomes (1)
Association Between MMP Genotypes and Healing Outcomes
The association between MMP-2 (rs243865) and MMP-3 (rs3025058) genotypes and radiographic healing outcomes will be evaluated. Genotype and allele distributions will be compared between healed and non-healed groups to determine the potential influence of genetic polymorphisms on periapical healing following root canal treatment.
Measured: Baseline (genotyping) and 12 months after treatment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2026
- Study start15 May 2026 (estimated)
- Primary completion25 May 2027 (estimated)
- Study completion25 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Apical PeriodontitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- TC Erciyes University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ayşe Tuğba Eminsoy Avcı, TC Erciyes University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07529964
- Sponsor's protocol ID
- 3
- Status last verified
- Apr 2026
- First submitted
- 8 Apr 2026
- Last updated
- 14 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No